CLAIRE DUKE: Open Payments
NPI 1114431822 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,698 in 156 payments from 20 companies in 2025. Trend: 2023 $2,984 · 2024 $5,342 · 2025 $3,698
Food & beverage: $2,558Consulting: $1,140
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 14 | $1,516 |
| ABBVIE INC. | 38 | $544 |
| Organon LLC | 12 | $251 |
| Novartis Pharmaceuticals Corporation | 7 | $165 |
| GENZYME CORPORATION | 10 | $159 |
| PFIZER INC. | 12 | $159 |
| LEO Pharma Inc. | 7 | $145 |
| Galderma Laboratories, L.P. | 24 | $139 |
| Lilly USA, LLC | 8 | $115 |
| Regeneron Healthcare Solutions, Inc. | 4 | $106 |
Products named: Bimzelx, RINVOQ, DUPIXENT, SKYRIZI, VTAMA, CIBINQO, NEMLUVIO, EBGLYSS.
Industry payments across SC — which companies pay providers there.
